TerrAscend (TSNDF) Asset Writedowns and Impairment (2021 - 2026)
TerrAscend (TSNDF) reported Asset Writedowns and Impairment of $239000.0 for Q1 2026, down 50.21% year-over-year from $480000.0 in Q1 2025, and down 64.7% quarter-over-quarter from $677000.0 in Q4 2025.
TerrAscend (TSNDF) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Asset Writedowns and Impairment data on file, last reported at $239000.0 in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $239000.0, down 50.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 70.56% YoY), and the FY2025 annual result was $1.7 million, down 45.48% from the prior year.
- Asset Writedowns and Impairment declined to $239000.0 in Q1 2026 per TSNDF's latest filing, from $677000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $152.9 million in Q3 2022 and troughed at -$154.0 million in Q4 2022.
- A 5-year average of $575470.6 and a median of $314000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 39314.43% in 2022 and fell as far as 5786.23% in 2022.
- A 5-year view of Asset Writedowns and Impairment shows it stood at -$154.0 million in 2022, then surged by 99.53% to -$728000.0 in 2023, then surged by 675.55% to $4.2 million in 2024, then plunged by 83.84% to $677000.0 in 2025, then plunged by 64.7% to $239000.0 in 2026.
- Business Quant data shows TSNDF's Asset Writedowns and Impairment at $239000.0 in Q1 2026, $677000.0 in Q4 2025, and $314000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239,000.00 |
| Mar 31, 2026 | 239,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 314,000.00 |
| Sep 30, 2025 | 314,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Mar 31, 2025 | 480,000.00 |
| Mar 31, 2025 | 480,000.00 |
| Dec 31, 2024 | 4.19 Mn |
| Dec 31, 2024 | 4.19 Mn |
| Sep 30, 2024 | 183,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | 2.44 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | -728,000.00 |
| Dec 31, 2023 | -728,000.00 |